» Articles » PMID: 37188519

Expression Profile of Cytokines and Chemokines in a Mouse High-altitude Cerebral Edema Model

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: High-altitude cerebral edema (HACE) is considered to be the end-stage of acute mountain sickness (AMS); however, its pathophysiological mechanism remains unknown. Increasing evidences support that inflammation is an important risk factor for the occurrence of HACE. Including our published papers, previous studies demonstrated that the levels of IL-6, IL-1β, and TNF-α in both serum and hippocampus were increased in the mouse HACE model induced by LPS stimulation combined with hypobaric hypoxia exposure; however, the expression profile of other cytokines and chemokines remains unknown.

Objective: This study was to analyze the expression profile of cytokines and chemokines in the HACE model.

Methods: The mouse HACE model was established by LPS stimulation combined with hypobaric hypoxia exposure (LH). The mice were divided into the normoxic group, LH-6 h group, LH-1 d group, and LH-7 d group. Brain water content (BWC) was determined using the wet/dry weight ratio. The levels of 30 cytokines and chemokines in the serum and hippocampal tissue were detected using LiquiChip. The mRNA expression of cytokines and chemokines in hippocampal tissue were determined by -PCR.

Results: In the current study, we found that the brain water content was increased after the combinational treatment of LPS and hypobaric hypoxia. The results of LiquiChip showed that, in the serum and hippocampal tissue, most factors in all 30 cytokines and chemokines were dramatically upregulated at 6 h, and then declined at the 1st d and 7th d. Among these factors, G-CSF, M-CSF, MCP-1, KC, MIG, Eotaxin, Rantes, IP10, IL-6, MIP-2, and MIP-1β were all increased in both serum and hippocampal tissue at 6 h. In addition, the results of -PCR showed the mRNA levels of G-CSF, MCP-1, KC, MIG, Eotaxin, Rantes, IP10, IL-6, MIP-2, and MIP-1β in hippocampal tissue were dramatically upregulated at 6 h.

Conclusion: This study showed that the dynamic expression profile of 30 cytokines and chemokines in a mouse HACE model induced by LPS plus hypobaric hypoxia. The levels of G-CSF, MCP-1, KC, MIG, Eotaxin, Rantes, IP10, IL-6, MIP-2, and MIP-1β in both serum and hippocampus were significantly increased at 6 h, which may be involved in the occurrence and development of HACE.

Citing Articles

Global profiling of protein lactylation in microglia in experimental high-altitude cerebral edema.

Jiang X, Gao J, Fei X, Geng Y, Yue X, Shi Z Cell Commun Signal. 2024; 22(1):374.

PMID: 39054523 PMC: 11271010. DOI: 10.1186/s12964-024-01748-x.


Astrogliosis in the GFAP-Cre:Rosa26 Mouse Model Does Not Exacerbate Retinal Microglia Activation or Müller Cell Gliosis under Hypoxic Conditions.

Rorex C, Cardona S, Church K, Rodriguez D, Vanegas D, Saldivar R Biomolecules. 2024; 14(5).

PMID: 38785974 PMC: 11117533. DOI: 10.3390/biom14050567.

References
1.
Semple B, Bye N, Rancan M, Ziebell J, Morganti-Kossmann M . Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab. 2009; 30(4):769-82. PMC: 2949175. DOI: 10.1038/jcbfm.2009.262. View

2.
Rumman M, Pandey S, Singh B, Gupta M, Ubaid S, Mahdi A . Genistein Prevents Hypoxia-Induced Cognitive Dysfunctions by Ameliorating Oxidative Stress and Inflammation in the Hippocampus. Neurotox Res. 2021; 39(4):1123-1133. DOI: 10.1007/s12640-021-00353-x. View

3.
Strecker J, Schmidt A, Schabitz W, Minnerup J . Neutrophil granulocytes in cerebral ischemia - Evolution from killers to key players. Neurochem Int. 2016; 107:117-126. DOI: 10.1016/j.neuint.2016.11.006. View

4.
Liu J, Wang J, Luo H, Li Z, Zhong T, Tang J . Screening cytokine/chemokine profiles in serum and organs from an endotoxic shock mouse model by LiquiChip. Sci China Life Sci. 2017; 60(11):1242-1250. DOI: 10.1007/s11427-016-9016-6. View

5.
Wilson C, Finch C, Cohen H . Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002; 50(12):2041-56. DOI: 10.1046/j.1532-5415.2002.50619.x. View